AHR and psoriasis: In murine and human models of psoriasis induced by imiquomod, the AhR stimulation with agonist FICZ resulted in attenuated psoriasiform skin inflammation, with milder parakeratosis and cell infiltration, a significant reduction in epidermal and scale thickness, and reduced expression of proinflammatory mediators [82].